全文获取类型
收费全文 | 11836篇 |
免费 | 827篇 |
国内免费 | 367篇 |
出版年
2023年 | 97篇 |
2022年 | 156篇 |
2021年 | 209篇 |
2020年 | 235篇 |
2019年 | 305篇 |
2018年 | 375篇 |
2017年 | 262篇 |
2016年 | 279篇 |
2015年 | 298篇 |
2014年 | 564篇 |
2013年 | 820篇 |
2012年 | 434篇 |
2011年 | 617篇 |
2010年 | 516篇 |
2009年 | 614篇 |
2008年 | 624篇 |
2007年 | 551篇 |
2006年 | 570篇 |
2005年 | 518篇 |
2004年 | 491篇 |
2003年 | 453篇 |
2002年 | 412篇 |
2001年 | 222篇 |
2000年 | 196篇 |
1999年 | 244篇 |
1998年 | 277篇 |
1997年 | 219篇 |
1996年 | 174篇 |
1995年 | 214篇 |
1994年 | 197篇 |
1993年 | 177篇 |
1992年 | 169篇 |
1991年 | 126篇 |
1990年 | 132篇 |
1989年 | 128篇 |
1988年 | 108篇 |
1987年 | 103篇 |
1986年 | 93篇 |
1985年 | 117篇 |
1984年 | 148篇 |
1983年 | 153篇 |
1982年 | 147篇 |
1981年 | 101篇 |
1980年 | 59篇 |
1979年 | 56篇 |
1978年 | 31篇 |
1977年 | 15篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
RBM5 is a known putative tumor suppressor gene that has been shown to function in cell growth inhibition by modulating apoptosis. RBM5 also plays a critical role in alternative splicing as an RNA binding protein. However, it is still unclear which domains of RBM5 are required for RNA binding and related functional activities. We hypothesized the two putative RNA recognition motif (RRM) domains of RBM5 spanning from amino acids 98–178 and 231–315 are essential for RBM5-mediated cell growth inhibition, apoptosis regulation, and RNA binding. To investigate this hypothesis, we evaluated the activities of the wide-type and mutant RBM5 gene transfer in low-RBM5 expressing A549 cells. We found that, unlike wild-type RBM5 (RBM5-wt), a RBM5 mutant lacking the two RRM domains (RBM5-ΔRRM), is unable to bind RNA, has compromised caspase-2 alternative splicing activity, lacks cell proliferation inhibition and apoptosis induction function in A549 cells. These data provide direct evidence that the two RRM domains of RBM5 are required for RNA binding and the RNA binding activity of RBM5 contributes to its function on apoptosis induction and cell growth inhibition. 相似文献
993.
Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor 下载免费PDF全文
Vikas Bhat Max B. Olenick Brett J. Schuchardt David C. Mikles Caleb B. McDonald Amjad Farooq 《Biopolymers》2014,101(6):573-582
B‐cell lymphoma extra‐large protein (BclXL) serves as an apoptotic repressor by virtue of its ability to recognize and bind to BH3 domains found within a diverse array of proapoptotic regulators. Herein, we investigate the molecular basis of the specificity of the binding of proapoptotic BH3 ligands to BclXL. Our data reveal that while the BH3 ligands harboring the LXXX[A/S]D and [R/Q]XLXXXGD motif bind to BclXL with high affinity in the submicromolar range, those with the LXXXGD motif afford weak interactions. This suggests that the presence of a glycine at the fourth position (G+4)—relative to the N‐terminal leucine (L0) within the LXXXGD motif—mitigates binding, unless the LXXXGD motif also contains arginine/glutamine at the ?2 position. Of particular note is the observation that the residues at the +4 and ?2 positions within the LXXX[A/S]D and [R/Q]XLXXXGD motifs appear to be energetically coupled—replacement of either [A/S]+4 or [R/Q]‐2 with other residues has little bearing on the binding affinity of BH3 ligands harboring one of these motifs. Collectively, our study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs. © 2013 Wiley Periodicals, Inc. Biopolymers 101: 573–582, 2014. 相似文献
994.
995.
996.
997.
998.
Senoo H Yoshikawa K Morii M Miura M Imai K Mezaki Y 《Cell biology international》2010,34(12):1247-1272
HSCs (hepatic stellate cells) (also called vitamin A-storing cells, lipocytes, interstitial cells, fat-storing cells or Ito cells) exist in the space between parenchymal cells and liver sinusoidal endothelial cells of the hepatic lobule and store 50-80% of vitamin A in the whole body as retinyl palmitate in lipid droplets in the cytoplasm. In physiological conditions, these cells play pivotal roles in the regulation of vitamin A homoeostasis. In pathological conditions, such as hepatic fibrosis or liver cirrhosis, HSCs lose vitamin A and synthesize a large amount of extracellular matrix components including collagen, proteoglycan, glycosaminoglycan and adhesive glycoproteins. Morphology of these cells also changes from the star-shaped SCs (stellate cells) to that of fibroblasts or myofibroblasts. The hepatic SCs are now considered to be targets of therapy of hepatic fibrosis or liver cirrhosis. HSCs are activated by adhering to the parenchymal cells and lose stored vitamin A during hepatic regeneration. Vitamin A-storing cells exist in extrahepatic organs such as the pancreas, lungs, kidneys and intestines. Vitamin A-storing cells in the liver and extrahepatic organs form a cellular system. The research of the vitamin A-storing cells has developed and expanded vigorously. The past, present and future of the research of the vitamin A-storing cells (SCs) will be summarized and discussed in this review. 相似文献
999.
1000.